Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Plos One
|
December 5, 2019
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study
Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, et al.
European Journal of Neurology
|
February 7, 2024
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
Ana Beatriz Gago-Veiga, Noelia Lopez-Alcaide, Sonia Quintas, et al.
Nature
|
August 27, 2025
Maternal stress triggers early-life eczema through fetal mast cell programming
Nadine Serhan, Nasser S Abdullah, Nadine Gheziel, et al.
Frontiers in Neurology
|
December 12, 2025
SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials
Cristina Sanabria-Gago, Iris Fernández Lázaro, Patricia Heredia, et al.
HIV Medicine
|
November 23, 2024
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)-GeSIDA study conducted by the GeSIDA 12021 study group
José-Ramón Blanco, Alicia Gonzalez-Baeza, Ana Martinez-Vicente, et al.
Science Translational Medicine
|
January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
Constantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.
Brain and Behavior
|
June 25, 2026
ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice
Alba Somovilla, Iris Fernández-Lázaro, Josué Pagán, et al.
The Journal of Headache and Pain
|
June 2, 2023
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
Albert Muñoz-Vendrell, Sergio Campoy, Edoardo Caronna, et al.
European Journal of Neurology
|
January 25, 2024
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
Celia Romero Del Rincón, Alicia Gonzalez-Martinez, Sonia Quintas, et al.
Plos Neglected Tropical Diseases
|
September 17, 2025
Differentiating proven progressive disseminated histoplasmosis from other diagnoses in hospitalized persons with HIV and suspected progressive disseminated histoplasmosis: Findings from a clinical and demographic study in Mexico
Maria Dolores Niembro-Ortega, Areli Martinez-Gamboa, Antonio Olivas-Martinez, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Plos One
|
December 5, 2019
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study
Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, et al.
European Journal of Neurology
|
February 7, 2024
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
Ana Beatriz Gago-Veiga, Noelia Lopez-Alcaide, Sonia Quintas, et al.
Nature
|
August 27, 2025
Maternal stress triggers early-life eczema through fetal mast cell programming
Nadine Serhan, Nasser S Abdullah, Nadine Gheziel, et al.
Frontiers in Neurology
|
December 12, 2025
SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials
Cristina Sanabria-Gago, Iris Fernández Lázaro, Patricia Heredia, et al.
HIV Medicine
|
November 23, 2024
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)-GeSIDA study conducted by the GeSIDA 12021 study group
José-Ramón Blanco, Alicia Gonzalez-Baeza, Ana Martinez-Vicente, et al.
Science Translational Medicine
|
January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
Constantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.
Brain and Behavior
|
June 25, 2026
ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice
Alba Somovilla, Iris Fernández-Lázaro, Josué Pagán, et al.
The Journal of Headache and Pain
|
June 2, 2023
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
Albert Muñoz-Vendrell, Sergio Campoy, Edoardo Caronna, et al.
European Journal of Neurology
|
January 25, 2024
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
Celia Romero Del Rincón, Alicia Gonzalez-Martinez, Sonia Quintas, et al.
Plos Neglected Tropical Diseases
|
September 17, 2025
Differentiating proven progressive disseminated histoplasmosis from other diagnoses in hospitalized persons with HIV and suspected progressive disseminated histoplasmosis: Findings from a clinical and demographic study in Mexico
Maria Dolores Niembro-Ortega, Areli Martinez-Gamboa, Antonio Olivas-Martinez, et al.
Page
of 13